Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,994.20 | 82.50 | -1.02% |
| CAC 40 | 8,187.65 | 56.24 | 0.69% |
| DAX 40 | 18,686.60 | 188.22 | 1.02% |
| Dow JONES (US) | 39,380.49 | 324.10 | 0.83% |
| FTSE 100 | 8,381.35 | 27.30 | 0.33% |
| HKSE | 18,537.81 | 223.95 | 1.22% |
| NASDAQ | 16,334.45 | 31.70 | 0.19% |
| Nikkei 225 | 38,073.98 | 128.39 | -0.34% |
| NZX 50 Index | 11,746.58 | 36.31 | -0.31% |
| S&P 500 | 5,210.11 | 22.44 | 0.43% |
| S&P/ASX 200 | 7,721.60 | 82.90 | -1.06% |
| SSE Composite Index | 3,154.32 | 25.84 | 0.83% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 8.11% |
| Sigma Healthcare Ltd SIG | 1.29 | 0.01 | -0.77% |
| Imugene Ltd IMU | 0.07 | 0.01 | -6.67% |
| Telstra Group Ltd TLS | 3.64 | 0.01 | -0.27% |
| South32 Ltd S32 | 3.62 | 0.03 | -0.82% |
| Vicinity Centres VCX | 1.92 | 0.02 | -1.03% |
| Westpac Banking Corp WBC | 26.32 | 1.57 | -5.63% |
| Pilbara Minerals Ltd PLS | 4.17 | 0.01 | -0.24% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
| Liontown Resources Ltd LTR | 1.40 | 0.07 | 5.26% |